These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 132667)

  • 1. Effect of deoxycorticosterone acetate and 16beta-hydroxy-dehydroepiandrosterone on blood pressure and plasma renin activity of rats.
    Ayachi S; Hall CE; Holland OB; Gomez-Sanchez C
    Proc Soc Exp Biol Med; 1976 Jun; 152(2):218-20. PubMed ID: 132667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure changes following chronic administration to rats of 3beta,16beta-dihydroxy-5-androsten-17-one, 3beta,17beta-dihydroxy-5-androsten-16-one and 21-hydroxy-4-pregnene-3,20-dione-21-acetate.
    Ogihara T; Ichihara K; Yamamoto T; Kumahara Y; Kircher HW; Nugent CA
    Steroids; 1977 Jan; 29(1):17-20. PubMed ID: 138980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a new mineralocorticoid in patients with low-renin essential hypertension.
    Sennett JA; Brown RD; Island DP; Yarbro LR; Watson JT; Slaton PE; Hollifield JW; Liddle GW
    Circ Res; 1975 Jun; 36(6 Suppl 1):2-9. PubMed ID: 124232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid activity of 16beta-hydroxydehydroepiandrosterone and related steroids.
    Gomez-Sanchez C; Holland OB; Higgins JR; Mathieu R; Gruber GM; Milewich L; Kaplan NM
    J Lab Clin Med; 1976 Oct; 88(4):571-7. PubMed ID: 135037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental hypertension and other responses to 18-hydroxy-deoxycorticosterone treatment in the rat.
    Hall CE; Gomez-Sanchez CE; Holland OB; Nasseth D; Hall O
    Endocrinology; 1978 Jul; 103(1):133-40. PubMed ID: 744064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New mineralocorticoids and adrenocorticosteroids in hypertension.
    Melby JC; Dale SL
    Am J Cardiol; 1976 Nov; 38(6):805-13. PubMed ID: 136892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mineralocorticoid and hypertensogenic properties of 16beta-hydroxy-dehydroepiandrosterone.
    Gomez-Sanchez C; Holland OB; Hall CE; Ayachi S
    Experientia; 1976 Aug; 32(8):1067-9. PubMed ID: 182526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of 16beta-hydroxydehydroepiandrosterone with renal mineralocorticoid receptors.
    Higgins JR; Wambach G; Kem DC; Gomez-Sanchez C; Holland OB; Kaplan NM
    J Lab Clin Med; 1977 Feb; 89(2):250-6. PubMed ID: 137938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mineralocorticoid activity and effect on blood pressure of synthetic 16beta-OH-dehydroepiandrosterone and 16-oxoandrostenediol in rats (author's transl)].
    Ogihara T; Ichihara K; Kumahara Y; Yamamoto T; Kircher HW; Nugent CA
    Nihon Naibunpi Gakkai Zasshi; 1977 Mar; 53(3):175-82. PubMed ID: 144073
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of 19-nor-deoxycorticosterone on blood pressure, saline consumption, and serum electrolytes, corticosterone, and renin activity.
    Hall CE; Gomez-Sanchez CE; Holland OB; Nasseth D
    Endocrinology; 1979 Sep; 105(3):600-4. PubMed ID: 157270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 16Beta-hydroxydehydroepiandrosterone: the dichotomy between renal receptor binding and urinary electrolyte activity.
    Funder JW; Robinson JA; Feldman D; Wynne KN; Adam WR
    Endocrinology; 1976 Aug; 99(2):619-28. PubMed ID: 182463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrolyte and hormonal effects of deoxycorticosterone acetate in young pigs.
    Grekin RJ; Terris JM; Bohr DF
    Hypertension; 1980; 2(3):326-32. PubMed ID: 6993359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salt appetite and hypertensive response to salt and to deoxycorticosterone in Sprague-Dawley and Long-Evans rats.
    Hall CE; Ayachi S; Hall O
    Tex Rep Biol Med; 1972; 30(2):143-53. PubMed ID: 5070570
    [No Abstract]   [Full Text] [Related]  

  • 14. Absence of renin suppression by deoxycorticosterone acetate in rats.
    Goodwin FJ; Knowlton AI; Laragh JH
    Am J Physiol; 1969 Jun; 216(6):1476-80. PubMed ID: 5786734
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibitors attenuate increased blood pressure in renovascular hypertensive models, but not in deoxycorticosterone-salt hypertension.
    Okumura T; Hayashi I; Ikezawa T; Yamanaka M; Takata T; Fujita Y; Saigenji K; Yamashina S; Majima M
    Hypertens Res; 2002 Nov; 25(6):927-38. PubMed ID: 12484518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyamines, vascular smooth muscle, and deoxycorticosterone acetate-salt hypertension.
    Soltis EE; Newman PS; Olson JW
    Hypertension; 1991 Jul; 18(1):85-92. PubMed ID: 1860716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of Fischer 344 rats to deoxycorticosterone hypertension.
    Hall CE; Hall O
    Life Sci; 1977 Apr; 20(7):1239-47. PubMed ID: 850474
    [No Abstract]   [Full Text] [Related]  

  • 18. 19-Hydroxyandrostenedione: evidence for a new class of sodium-retaining and hypertensinogenic steroids.
    Sekihara H
    Endocrinology; 1983 Sep; 113(3):1141-8. PubMed ID: 6347666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5 alpha-Dihydro-11-deoxycorticosterone: effect on blood pressure in the rat.
    Carroll J; Komanicky P; Melby JC
    Steroids; 1981 Jan; 37(1):111-20. PubMed ID: 7222141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aminoglutethimide on blood pressure and steroid secretion in patients with low renin essential hypertension.
    Taylor AA; Mitchell JR; Bartter FC; Snodgrass WR; McMurtry RJ; Gill JR; Franklin RB
    J Clin Invest; 1978 Jul; 62(1):162-8. PubMed ID: 149141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.